Document is current
Any future updates will be listed below
-
Authors
Arvidsson McShane, Staffan
Norinder, Ulf
Alvarsson, Jonathan
Ahlberg, Ernst
Carlsson, Lars
Spjuth, Ola
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2020-03731)
Svenska Forskningsrådet Formas (2022-00940)
Cancerfonden (22 2412)
HORIZON EUROPE Framework Programme (101057014)
Uppsala University
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 11 June 2024
First Online: 28 June 2024
Declarations
:
: OS is the owner of Aros Bio AB, providing commercial licenses of CPSign. Both JA and SAM have previously been employed at Genetta Soft which at the time owned the rights to CPSign.
